Business- Page 27

Announces Third Quarter 2026 Net Earnings Growth of 1.5% Manhattan, KS, Oct. 28, 2026 (GLOBE NEWSWIRE) — Landmark Bancorp, Inc. (“Landmark”; Nasdaq: LARK) reported diluted earnings per share of $0.89 for the

Raises 2026 revenue guidance to 20% year over year growth Highlights Revenue grew 20% year over year to $2.08 billion Product revenue grew 37% year over year to $765 million Billings grew

Tenable Exceeds Q3 Revenue and Profit Expectations, Raises Full-Year Outlook Revenue of $276.4 million, year-over-year growth of 9.5% GAAP operating margin of 6.0%; Non-GAAP operating margin of 27.1%, year-over-year increase of 380

SUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) — Adamas Trust, Inc. (Nasdaq: ADAM) (“Adamas,” the “Company,” “we,” “our” or “us”) today reported results for the three and nine months ended September 30,

Call Scheduled for 10:00 am ET on Friday, November 6, 2026 VIENNA, Va., Oct. 28, 2026 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (“Castellum” or the “Company”), a defense tech services and

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) announced today that it will release its financial results for the third quarter

Dosing ongoing in fully recruited dose level 2 of MP0712 Phase 1/2a study; initial safety data to be presented at North America Conference on Lung Cancer in December 2026, efficacy data expected

Revenue Increased 7% Year-over-Year to $70.5 Million, With Growth Across Wholesale and Retail Channels Wholesale Revenue Increased 40% Year-Over-Year to $9.7 Million, Setting Second Consecutive Quarterly Record Virginia Achieved Record Retail and Delivery

Published in Nature Communications, the study found a 10-protein signature that outperformed a leading individual ALS biomarker, including in some patients with difficult-to-diagnose presentations Fremont, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) —